Thomas Vincent

Senior Director of Antibody Technology at Alloy Therapeutics

Speaker

Tom Vincent is Senior Director of Antibody Technology at Alloy Therapeutics. With over 20 years of drug discovery experience, he is a core member of the antibody discovery team, where he co-developed the SeqImmune™ workflow. Prior to his work at Alloy, he focused on therapeutic antibody discovery and engineering at Abeome Corp. Previously, Tom also worked at Ionis Pharmaceuticals and Regulus Therapeutics, where he was a key contributor to multiple successful preclinical and clinical programs in RNA-based therapeutics.